With Super Bowl 59 officially in the books, it's time for teams to kickstart their offseason. The New England Patriots already made sweeping changes once the 2024 season concluded, completely revamping their coaching staff with Mike Vrabel at the helm.
Now, the Patriots have turned their attention to building out the roster. With that in mind, they have made their first big transaction of the offseason, re-signing defensive tackle Jeremiah Pharms Jr, per Patriots insider Mike Reiss.
Patriots DT Jeremiah Pharms Jr., who was an exclusive rights free agent, has agreed to a 2-year deal, according to his agency @OSMG_LLC.
— Mike Reiss (@MikeReiss) February 11, 2025
The deal is expected to include a $100k signing bonus and $250k guaranteed.
If Pharms sticks on the roster in 2025, he would avoid the…
The contract is for two years, according to his agency, and includes $250K guaranteed with a $100K signing bonus. That's a notable investment to get the 28-year-old back on the team's 53-man roster.
Patriots News: New England Re-Signs Jeremiah Pharms Jr.
This is an exciting development for the undrafted free agent. Pharms has had a wild journey to the NFL. He played for Sacramento City College, San Joaquin Delta College, and Friends University during his collegiate career.
After going undrafted in 2019, Pharms spent time with the Wichita Force of the Champions Indoor Football League and the Pittsburgh Maulers of the USFL, before joining the Patriots practice squad in the summer of 2022.
After getting his first opportunity in the NFL in 2023, Pharms had an unexpected breakout season last year, playing 16 games and in 43% of defensive snaps for the Patriots, even starting five games.
Pharms finished the season with two sacks, four tackles for loss, and five QB hits and received a 58.1 defensive grade on Pro Football Focus. That made him the 61st-best interior defensive lineman in the league.
The 28-year-old defender received endless praise from former defensive coordinator DeMarcus Covington and DL coach Jerry Montgomery for his work ethic. ESPN's Reiss pointed out the 5 am film study sessions between Montgomery and Pharms throughout the season.
What the Patriots' 53-man roster will look like remains to be seen, but Pharms is now a good bet to be a part of the defensive unit and play a big role again next season.